OpenMolDB

Glycocholate anion

MW	HBA	HBD	LogP	CAS	Suppliers	Supplier IDs	Storage ID	Quantity	Class	PAINS
464.61	9	4	1.62				nt1347	None		Not checked

SMILES: O[C@@H]1CC[C@]2(C)[C@@]3([H])C[C@H](O)[C@]4(C)[C@@H]([C@H](C)CCC(NCC([O-])=O)=O)CC[C@@]4([H])[C@]3([H])[C@H](O)CC2C1

Supramolecules

Name	log K	SD	pH	T(°C)	Method	Ref
[b-Cyclodextrin](1).[Glycocholate anion]	3.29			25.0		Kenneth A. Connors 1995

Glycocholate anion

MW	HBA	HBD	LogP	CAS	Suppliers	Supplier IDs	Storage ID	Quantity	Class	PAINS
464.61	9	4	1.62				nt1348	None		Not checked

SMILES: O[C@@H]1CC[C@]2(C)[C@@]3([H])C[C@H](O)[C@]4(C)[C@@H]([C@H](C)CCC(NCC([O-])=O)=O)CC[C@@]4([H])[C@]3([H])[C@H](O)CC2C1

Supramolecules

Name	log K	SD	pH	T(°C)	Method	Ref

Gly–b-D-Asp–D-PheNH2

MW	HBA	HBD	LogP	CAS	Suppliers	Supplier IDs	Storage ID	Quantity	Class	PAINS
	None	None					SF_C1466	None

SMILES:

Supramolecules

Name	log K	SD	pH	T(°C)	Method	Ref
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[Gly–b-D-Asp–D-PheNH2]	1.75		3.6	20.0	Capillary electrophoresis	Gerhard K.E. Scriba 1999
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[Gly–b-D-Asp–D-PheNH2]	1.35		5.25	20.0	Capillary electrophoresis	Gerhard K.E. Scriba 1999

Gly–b-L-Asp–D-PheNH2

MW	HBA	HBD	LogP	CAS	Suppliers	Supplier IDs	Storage ID	Quantity	Class	PAINS
	None	None					SF_C1463	None

SMILES:

Supramolecules

Name	log K	SD	pH	T(°C)	Method	Ref
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[Gly–b-L-Asp–D-PheNH2]	1.66		3.6	20.0	Capillary electrophoresis	Gerhard K.E. Scriba 1999
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[Gly–b-L-Asp–D-PheNH2]	1.59		5.25	20.0	Capillary electrophoresis	Gerhard K.E. Scriba 1999

Gly–b-L-Asp–L-PheNH2

MW	HBA	HBD	LogP	CAS	Suppliers	Supplier IDs	Storage ID	Quantity	Class	PAINS
	None	None					SF_C1465	None

SMILES:

Supramolecules

Name	log K	SD	pH	T(°C)	Method	Ref
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[Gly–b-L-Asp–L-PheNH2]	1.84		3.6	20.0	Capillary electrophoresis	Gerhard K.E. Scriba 1999
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[Gly–b-L-Asp–L-PheNH2]	1.43		5.25	20.0	Capillary electrophoresis	Gerhard K.E. Scriba 1999

HO(CH2)3NH2

MW	HBA	HBD	LogP	CAS	Suppliers	Supplier IDs	Storage ID	Quantity	Class	PAINS
	None	None					JN_258	None

SMILES:

Supramolecules

Name	log K	SD	pH	T(°C)	Method	Ref
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[HO(CH2)3NH2]	0.25	-1.52	11.6	25.0	displacement of a fluorescent probe	Oswald S.Tee 1996

HO(CH2)6OH

MW	HBA	HBD	LogP	CAS	Suppliers	Supplier IDs	Storage ID	Quantity	Class	PAINS
118.17	2	2	0.53				SF_C1288	None		Not checked

SMILES: C(CCCO)CCO

Supramolecules

Name	log K	SD	pH	T(°C)	Method	Ref
[b-Cyclodextrin](1).[HO(CH2)6OH]	1.54	0.77	11.6	25.0	UV-vis spectroscopy	Oswald S. Tee 1993

HOO˙ adduct of 4-Et-PBNOH

MW	HBA	HBD	LogP	CAS	Suppliers	Supplier IDs	Storage ID	Quantity	Class	PAINS
	None	None					VR_C178	None

SMILES:

Supramolecules

Name	log K	SD	pH	T(°C)	Method	Ref
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[HOO˙ adduct of 4-Et-PBNOH]	2.89				ESR (EPR)	Jean-Pierre Finet, Paul Tordo 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[HOO˙ adduct of 4-Et-PBNOH]	2.99				ESR (EPR)	Jean-Pierre Finet, Paul Tordo 2005

HOO˙ adduct of 4-Me-PBNOH

MW	HBA	HBD	LogP	CAS	Suppliers	Supplier IDs	Storage ID	Quantity	Class	PAINS
	None	None					VR_C177	None

SMILES:

Supramolecules

Name	log K	SD	pH	T(°C)	Method	Ref
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[HOO˙ adduct of 4-Me-PBNOH]	2.51				ESR (EPR)	Jean-Pierre Finet, Paul Tordo 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[HOO˙ adduct of 4-Me-PBNOH]	2.61				ESR (EPR)	Jean-Pierre Finet, Paul Tordo 2005

HOO˙ adduct of PBN

MW	HBA	HBD	LogP	CAS	Suppliers	Supplier IDs	Storage ID	Quantity	Class	PAINS
	None	None					VR_C175	None

SMILES:

Supramolecules

Name	log K	SD	pH	T(°C)	Method	Ref
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[HOO˙ adduct of PBN]	2.74				ESR (EPR)	Jean-Pierre Finet, Paul Tordo 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[HOO˙ adduct of PBN]	2.92				ESR (EPR)	Jean-Pierre Finet, Paul Tordo 2005

HOO˙ adduct of PBNOH

MW	HBA	HBD	LogP	CAS	Suppliers	Supplier IDs	Storage ID	Quantity	Class	PAINS
	None	None					VR_C176	None

SMILES:

Supramolecules

Name	log K	SD	pH	T(°C)	Method	Ref
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[HOO˙ adduct of PBNOH]	2.78				ESR (EPR)	Jean-Pierre Finet, Paul Tordo 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[HOO˙ adduct of PBNOH]	3.01				ESR (EPR)	Jean-Pierre Finet, Paul Tordo 2005

Heptakis(2,3,6-tri-O-Methyl)-b-Cyclodextrin

MW	HBA	HBD	LogP	CAS	Suppliers	Supplier IDs	Storage ID	Quantity	Class	PAINS
	None	None					CY-2003	None

SMILES:

Supramolecules

Name	log K	SD	pH	T(°C)	Method	Ref
[Heptakis(2,3,6-tri-O-Methyl)-b-Cyclodextrin](1).[(S)-1,7-dioxaspiro[5.5]undecane]	2.98	1.97	7.0	25.0	NMR spectroscopy	Irene M. Mavridis 2001
[Heptakis(2,3,6-tri-O-Methyl)-b-Cyclodextrin](1).[(R)-1,7-dioxaspiro[5.5]undecane]	2.57	1.52	7.0	25.0	NMR spectroscopy	Irene M. Mavridis 2001
[Heptakis(2,3,6-tri-O-Methyl)-b-Cyclodextrin](0.5).[Chlorophyll a]	0.95	0.30	7.0		Fluorescence spectroscopy	Lucia Catucci 2005
[Heptakis(2,3,6-tri-O-Methyl)-b-Cyclodextrin](1).[rose bengal]	2.08	0.85	7.0	25.0	UV-Vis spectroscopy	P. Fini 2004
[Heptakis(2,3,6-tri-O-Methyl)-b-Cyclodextrin](1).[rose bengal]	1.95	1.00	7.0	25.0	Calorimetry	P. Fini 2004
[Heptakis(2,3,6-tri-O-Methyl)-b-Cyclodextrin](1).[Benzyl tert-butyl nitroxide]	1.33		7.0	21.0	EPR spectroscopy	Marco Lucarini 2004
[Heptakis(2,3,6-tri-O-Methyl)-b-Cyclodextrin](1).[4-hydroxyphenylmethanol]	1.81	0.60	7.0	25.0	Fluorescence spectroscopy	Koji Kano 1992
[Heptakis(2,3,6-tri-O-Methyl)-b-Cyclodextrin](1).[2-(4-hydroxyphenyl)ethanol]	1.81		7.0	25.0	Fluorescence spectroscopy	Koji Kano 1992
[Heptakis(2,3,6-tri-O-Methyl)-b-Cyclodextrin](1).[3-(4-hydroxyphenyl)propanol]	2.03	0.48	7.0	25.0	Fluorescence spectroscopy	Koji Kano 1992
[Heptakis(2,3,6-tri-O-Methyl)-b-Cyclodextrin](1).[3-(4-hydroxyphenyl)propanol]	2.20		7.0	10.0	Fluorescence spectroscopy	Koji Kano 1992
[Heptakis(2,3,6-tri-O-Methyl)-b-Cyclodextrin](1).[3-(4-hydroxyphenyl)propanol]	2.14		7.0	15.0	Fluorescence spectroscopy	Koji Kano 1992
[Heptakis(2,3,6-tri-O-Methyl)-b-Cyclodextrin](1).[3-(4-hydroxyphenyl)propanol]	2.10		7.0	18.0	Fluorescence spectroscopy	Koji Kano 1992
[Heptakis(2,3,6-tri-O-Methyl)-b-Cyclodextrin](1).[3-(4-hydroxyphenyl)propanol]	1.93		7.0	30.0	Fluorescence spectroscopy	Koji Kano 1992
[Heptakis(2,3,6-tri-O-Methyl)-b-Cyclodextrin](1).[4-ethylphenol]	2.13	0.70	7.0	25.0	Fluorescence spectroscopy	Koji Kano 1992
[Heptakis(2,3,6-tri-O-Methyl)-b-Cyclodextrin](1).[4-propylphenol]	2.55	1.30	7.0	25.0	Fluorescence spectroscopy	Koji Kano 1992
[Heptakis(2,3,6-tri-O-Methyl)-b-Cyclodextrin](1).[4-butylphenol]	3.01	1.56	7.0	25.0	Fluorescence spectroscopy	Koji Kano 1992
[Heptakis(2,3,6-tri-O-Methyl)-b-Cyclodextrin](1).[2-(2-fluoro-4-biphenylyl)propionic acid]	3.38		7.0	15.0	UV-vis spectroscopy	Kaneto Uekama 1985
[Heptakis(2,3,6-tri-O-Methyl)-b-Cyclodextrin](1).[2-(2-fluoro-4-biphenylyl)propionic acid]	3.17		7.0	25.0	UV-vis spectroscopy	Kaneto Uekama 1985
[Heptakis(2,3,6-tri-O-Methyl)-b-Cyclodextrin](1).[2-(2-fluoro-4-biphenylyl)propionic acid]	2.68		7.0	37.0	UV-vis spectroscopy	Kaneto Uekama 1985
[Heptakis(2,3,6-tri-O-Methyl)-b-Cyclodextrin](1).[2-(2-fluoro-4-biphenylyl)propionic acid]	2.34		7.0	45.0	UV-vis spectroscopy	Kaneto Uekama 1985
[Heptakis(2,3,6-tri-O-Methyl)-b-Cyclodextrin](1).[L-tryptophan]	2.93	2.35	8.0	18.0	UV-vis spectroscopy	Andrzej Temeriusz 2006
[Heptakis(2,3,6-tri-O-Methyl)-b-Cyclodextrin](1).[paclitaxel]	2.55		7.0	25.0	HPLC-method	Massimo Fresta 2002
[Heptakis(2,3,6-tri-O-Methyl)-b-Cyclodextrin](1).[paclitaxel]	2.35		7.0	37.0	HPLC-method	Massimo Fresta 2002
[Heptakis(2,3,6-tri-O-Methyl)-b-Cyclodextrin](1).[paclitaxel]	2.01		7.0	45.0	HPLC-method	Massimo Fresta 2002
[Heptakis(2,3,6-tri-O-Methyl)-b-Cyclodextrin](1).[gemfibrozil]	1.31		11.4	25.0	NMR spectroscopy	Rosa Amoroso 2005
[Heptakis(2,3,6-tri-O-Methyl)-b-Cyclodextrin](1).[R-2-T5]	2.11	1.34				George W. Gokel 2003
[Heptakis(2,3,6-tri-O-Methyl)-b-Cyclodextrin](1).[S-2-T5]	2.11	1.34				George W. Gokel 2003
[Heptakis(2,3,6-tri-O-Methyl)-b-Cyclodextrin](1).[R-3-T7]	1.23	-1.00				George W. Gokel 2003
[Heptakis(2,3,6-tri-O-Methyl)-b-Cyclodextrin](2).[S-3-T7]	4.70	4.00				George W. Gokel 2003
[Heptakis(2,3,6-tri-O-Methyl)-b-Cyclodextrin](1).[R-4-T7]	2.62	1.20				George W. Gokel 2003
[Heptakis(2,3,6-tri-O-Methyl)-b-Cyclodextrin](1).[S-4-T7]	2.57	1.26				George W. Gokel 2003
[Heptakis(2,3,6-tri-O-Methyl)-b-Cyclodextrin](1).[R-7-T7]	2.24	1.04				George W. Gokel 2003
[Heptakis(2,3,6-tri-O-Methyl)-b-Cyclodextrin](1).[S-7-T7]	2.57	1.52				George W. Gokel 2003
[Heptakis(2,3,6-tri-O-Methyl)-b-Cyclodextrin](1).[R-1-T7]	2.84	1.62				George W. Gokel 2003
[Heptakis(2,3,6-tri-O-Methyl)-b-Cyclodextrin](1).[S-1-T7]	2.06	0.60				George W. Gokel 2003
[Heptakis(2,3,6-tri-O-Methyl)-b-Cyclodextrin](1).[R-C8]	0.85	0.48	7.0	25.0	NMR spectroscopy	George W. Gokel 2003
[Heptakis(2,3,6-tri-O-Methyl)-b-Cyclodextrin](1).[S-C8]	0.90	0.48	7.0	25.0	NMR spectroscopy	George W. Gokel 2003
[Heptakis(2,3,6-tri-O-Methyl)-b-Cyclodextrin](1).[R-C1]	1.87	0.70	7.0	25.0	NMR spectroscopy	George W. Gokel 2003
[Heptakis(2,3,6-tri-O-Methyl)-b-Cyclodextrin](1).[S-C1]	1.81	0.60	7.0	25.0	NMR spectroscopy	George W. Gokel 2003
[Heptakis(2,3,6-tri-O-Methyl)-b-Cyclodextrin](1).[L-Phe-L-Phe]	1.73				Capillary electrophoresis	Bezhan Chankvetadze 2004
[Heptakis(2,3,6-tri-O-Methyl)-b-Cyclodextrin](1).[D-Phe-D-Phe]	1.75				Capillary electrophoresis	Bezhan Chankvetadze 2004
[Heptakis(2,3,6-tri-O-Methyl)-b-Cyclodextrin](1).[L-Ala-L-Tyr]	1.43				Capillary electrophoresis	Bezhan Chankvetadze 2004
[Heptakis(2,3,6-tri-O-Methyl)-b-Cyclodextrin](1).[D-Ala-D-Tyr]	1.49				Capillary electrophoresis	Bezhan Chankvetadze 2004
[Heptakis(2,3,6-tri-O-Methyl)-b-Cyclodextrin](1).[coumarin 156]	3.09	2.09	7.0	20.0	UV-Vis spectroscopy and fluorescence spectroscopy	Kankan Bhattacharyya 2005
[Heptakis(2,3,6-tri-O-Methyl)-b-Cyclodextrin](2).[coumarin 156]	4.59	3.59	7.0	20.0	UV-Vis spectroscopy and fluorescence spectroscopy	Kankan Bhattacharyya 2005
[Heptakis(2,3,6-tri-O-Methyl)-b-Cyclodextrin](1).[1’,3’,3’-trimethylspiro[2H-1-benzopyran-2,2’-indoline]-6-sulphonate]	2.24	0.85	6.9	40.0	UV-vis spectroscopy	Yoshimi Sueishi 2005
[Heptakis(2,3,6-tri-O-Methyl)-b-Cyclodextrin](1).[ketoconazole]	2.73	1.48	6.0	25.0	UV-vis spectroscopy	Joanna Taraszewska 2005
[Heptakis(2,3,6-tri-O-Methyl)-b-Cyclodextrin](1).[harmane]	1.36	1.15	7.8	22.0	Fluorescence spectroscopy	B. del Castillo 2003
[Heptakis(2,3,6-tri-O-Methyl)-b-Cyclodextrin](1).[harmine]	2.32	1.53	7.8	22.0	Fluorescence spectroscopy	B. del Castillo 2003
[Heptakis(2,3,6-tri-O-Methyl)-b-Cyclodextrin](1).[5,10,15-tris(3,5-dicarboxylatophenyl)-20-phenylporphyrin]	6.84	5.60	7.0	25.0	Isothermal titration calorimetry	Koji Kano 2005
[Heptakis(2,3,6-tri-O-Methyl)-b-Cyclodextrin](1).[endo-8-azibicyclo[3.2.1]octan-3-ol]	2.66	1.78		27.0	NMR	Udo H. Brinker 2004
[Heptakis(2,3,6-tri-O-Methyl)-b-Cyclodextrin](1).[endo-8-azibicyclo[3.2.1]octan-3-ol]	2.74	1.78		20.0	Induced circular dichroism spectroscopy	Udo H. Brinker 2004
[Heptakis(2,3,6-tri-O-Methyl)-b-Cyclodextrin](1).[palmoic acid]	2.40	1.00	10.8	25.0	fluorescence spectroscopy, circular dichroism	Koji Kano 1991
[Heptakis(2,3,6-tri-O-Methyl)-b-Cyclodextrin](1).[2,2'-dihydroxy-1,1'-dinaphthylmethane]	2.15	0.70	5.5	25.0	fluorescence spectroscopy, circular dichroism	Koji Kano 1991
[Heptakis(2,3,6-tri-O-Methyl)-b-Cyclodextrin](1).[3-hydroxy-2-naphthoic acid]	2.66	0.48	5.5	25.0	fluorescence spectroscopy, circular dichroism	Koji Kano 1991

Heptakis(2,3-di-O-hexanoyl)-tetrakis(6-O-sulfo)cyclomaltoheptaose

MW	HBA	HBD	LogP	CAS	Suppliers	Supplier IDs	Storage ID	Quantity	Class	PAINS
	None	None					VD-0169	None

SMILES:

Supramolecules

Name	log K	SD	pH	T(°C)	Method	Ref
[Heptakis(2,3-di-O-hexanoyl)-tetrakis(6-O-sulfo)cyclomaltoheptaose](1).[acyclovir]	3.22		7.0	25.0	UV-vis spectroscopy	Helene Parrot-Lopez 2003

Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%

MW	HBA	HBD	LogP	CAS	Suppliers	Supplier IDs	Storage ID	Quantity	Class	PAINS
	None	None					CY-2004.0	None

SMILES:

Supramolecules

Name	log K	SD	pH	T(°C)	Method	Ref
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[papaverine]	2.19		7.4	37.0	Higuchi and Connors method	G. Puglisi 1998
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[Cholesterol]	5.74			25.0	Potential of mean force	Wensheng Cai 2006
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[2,3-dihydroxinaphtalene]	2.14	1.15			SPR experiments	Michael J. Sepaniak 2003
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[2,7-dihydroxinaphtalene]	2.16	1.15			SPR experiments	Michael J. Sepaniak 2003
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[benzene]	1.56	0.90			SPR experiments	Michael J. Sepaniak 2003
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[benzoic acid]	1.62	1.15			SPR experiments	Michael J. Sepaniak 2003
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[phenol]	1.52	1.08			SPR experiments	Michael J. Sepaniak 2003
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[ephedrine]	1.75	1.26			SPR experiments	Michael J. Sepaniak 2003
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[tolazoline]	2.03	1.63			SPR experiments	Michael J. Sepaniak 2003
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[Polyethylene glycol (n = 9.5) n-octylphenyl ether]	4.18	3.00	7.0	25.0	Fluorescence and phosporescence spectroscopy	Xinzhen Du 2005
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[polyethylene glycol (n = 10) tert-octylphenyl ether]	4.78	3.94	7.0	25.0	Fluorescence and phosporescence spectroscopy	Xinzhen Du 2005
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[rose bengal]	1.80	0.30	7.0	25.0	UV-Vis spectroscopy	P. Fini 2004
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[rose bengal]	1.83	1.18	7.0	25.0	Calorimetry	P. Fini 2004
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[Benzyl tert-butyl nitroxide]	3.03		7.0	21.0	EPR spectroscopy	Marco Lucarini 2004
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[dibenzyl nitroxide]	2.73		7.0	21.0	EPR spectroscopy	Marco Lucarini 2004
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[di-tert amyl nitroxide]	3.18		7.0	21.0	EPR spectroscopy	Marco Lucarini 2004
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[budesonide]	3.52	2.20	7.0	37.0	UV-vis spectroscopy	Helena M. Cabral Marques 2002
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[eugenol]	4.97		7.0	20.0	UV-vis spectroscopy	Le Xin Song 2005
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[4-hydroxyphenylmethanol]	2.39	1.30	7.0	25.0	Fluorescence spectroscopy	Koji Kano 1992
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[2-(4-hydroxyphenyl)ethanol]	2.39	1.32	7.0	25.0	Fluorescence spectroscopy	Koji Kano 1992
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[3-(4-hydroxyphenyl)propanol]	3.13	1.00	7.0	25.0	Fluorescence spectroscopy	Koji Kano 1992
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[3-(4-hydroxyphenyl)propanol]	3.19		7.0	10.0	Fluorescence spectroscopy	Koji Kano 1992
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[3-(4-hydroxyphenyl)propanol]	3.16		7.0	15.0	Fluorescence spectroscopy	Koji Kano 1992
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[3-(4-hydroxyphenyl)propanol]	3.14		7.0	20.0	Fluorescence spectroscopy	Koji Kano 1992
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[3-(4-hydroxyphenyl)propanol]	3.11		7.0	30.0	Fluorescence spectroscopy	Koji Kano 1992
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[4-ethylphenol]	2.96	1.00	7.0	25.0	Fluorescence spectroscopy	Koji Kano 1992
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[4-propylphenol]	3.53	2.37	7.0	25.0	Fluorescence spectroscopy	Koji Kano 1992
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[retinol]	3.77			25.0	UV-vis spectroscopy	Qing-Xiang Guo 1995
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[retinal]	3.75			25.0	UV-vis spectroscopy	Qing-Xiang Guo 1995
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[retinoic acid]	3.75			25.0	UV-vis spectroscopy	Qing-Xiang Guo 1995
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[sodium perfluoroctanoate]	3.40	2.78	7.0	25.0	Conductivity measurements	Emilio Aicart 1996
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[2-(2-fluoro-4-biphenylyl)propionic acid]	4.09		7.0	15.0	UV-vis spectroscopy	Kaneto Uekama 1985
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[2-(2-fluoro-4-biphenylyl)propionic acid]	4.00		7.0	25.0	UV-vis spectroscopy	Kaneto Uekama 1985
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[2-(2-fluoro-4-biphenylyl)propionic acid]	3.97		7.0	37.0	UV-vis spectroscopy	Kaneto Uekama 1985
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[2-(2-fluoro-4-biphenylyl)propionic acid]	3.93		7.0	45.0	UV-vis spectroscopy	Kaneto Uekama 1985
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[cyclosporin A]	3.02		7.0	25.0	HPLC-method	Kaneto Uekama 1999
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](2).[cyclosporin A]	1.32		7.0	25.0	HPLC-method	Kaneto Uekama 1999
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[paclitaxel]	2.61		7.0	25.0	HPLC-method	Massimo Fresta 2002
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[paclitaxel]	2.49		7.0	37.0	HPLC-method	Massimo Fresta 2002
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[paclitaxel]	2.43		7.0	45.0	HPLC-method	Massimo Fresta 2002
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[R-11-T7]	2.83	1.26				George W. Gokel 2003
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[S-11-T7]	2.77	1.45				George W. Gokel 2003
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[L-Ala-L-Tyr]	1.95				Capillary electrophoresis	Bezhan Chankvetadze 2004
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[D-Ala-D-Tyr]	2.00				Capillary electrophoresis	Bezhan Chankvetadze 2004
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[L-Asp-L-PheOMe]	1.86				Capillary electrophoresis	Bezhan Chankvetadze 2004
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[D-Asp-D-PheOMe]	1.92				Capillary electrophoresis	Bezhan Chankvetadze 2004
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[cypermethrin]	3.30		7.0	20.0	UV-vis spectroscopy	Judit Orgoványi 2005
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[coumarin 156]	2.34	1.34	7.0	20.0	UV-Vis spectroscopy and fluorescence spectroscopy	Kankan Bhattacharyya 2005
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](2).[coumarin 156]	3.53	2.53	7.0	20.0	UV-Vis spectroscopy and fluorescence spectroscopy	Kankan Bhattacharyya 2005
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[1’,3’,3’-trimethylspiro[2H-1-benzopyran-2,2’-indoline]-6-sulphonate]	3.33	2.78	6.9	40.0	UV-vis spectroscopy	Yoshimi Sueishi 2005
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[Phenol]	2.34	0.30	6.9	40.0	UV-vis spectroscopy	Yoshimi Sueishi 2005
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[4-CH3-Phenol]	2.64	0.70	6.9	40.0	UV-vis spectroscopy	Yoshimi Sueishi 2005
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[4-NO2-Phenol]	2.85	1.32	6.9	40.0	UV-vis spectroscopy	Yoshimi Sueishi 2005
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[2-Naphthol]	2.78	1.26	6.9	40.0	UV-vis spectroscopy	Yoshimi Sueishi 2005
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[4-CH3(CH2)4-phenol]	2.10	0.78	6.9	40.0	UV-vis spectroscopy	Yoshimi Sueishi 2005
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[4-CH3(CH2)5-phenol]	2.37	0.78	6.9	40.0	UV-vis spectroscopy	Yoshimi Sueishi 2005
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[ketoconazole]	4.38	2.70	6.0	25.0	UV-vis spectroscopy	Joanna Taraszewska 2005
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[ketoconazole]	3.54	2.18	5.0	25.0	UV-vis spectroscopy	Joanna Taraszewska 2005
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[ketoconazole]	4.48	3.00	6.0	20.0	UV-vis spectroscopy	Joanna Taraszewska 2005
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[ketoconazole]	4.18	2.70	6.0	35.0	UV-vis spectroscopy	Joanna Taraszewska 2005
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[ketoconazole]	4.06	2.30	6.0	45.0	UV-vis spectroscopy	Joanna Taraszewska 2005
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[iodine]	3.00		7.0	25.0	Sodium thiosulfate titration	Lajos Szente 1999
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[BMS-191435(R)]	1.83		2.58	25.0	Chiral capillary electrophoresis	Jinping Liu 1997
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[BMS-191435(S)]	1.93		2.58	25.0	Chiral capillary electrophoresis	Jinping Liu 1997
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[PBN]	1.71	0.60		27.0	NMR	Jean-Pierre Finet, Paul Tordo 2005
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[PBNOH]	1.48	0.30		27.0	NMR	Jean-Pierre Finet, Paul Tordo 2005
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[4-Me-PBNOH]	1.81	0.60		27.0	NMR	Jean-Pierre Finet, Paul Tordo 2005
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[4-Et-PBNOH]	2.31	1.18		27.0	NMR	Jean-Pierre Finet, Paul Tordo 2005
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[HOO˙ adduct of PBN]	2.74				ESR (EPR)	Jean-Pierre Finet, Paul Tordo 2005
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[HOO˙ adduct of PBNOH]	2.78				ESR (EPR)	Jean-Pierre Finet, Paul Tordo 2005
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[HOO˙ adduct of 4-Me-PBNOH]	2.51				ESR (EPR)	Jean-Pierre Finet, Paul Tordo 2005
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[HOO˙ adduct of 4-Et-PBNOH]	2.89				ESR (EPR)	Jean-Pierre Finet, Paul Tordo 2005
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[celecoxib]	3.95		7.0	25.0	NMR spectroscopy	Cinzia AnnaVentura 2005
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[celecoxib]	2.54		7.0	37.0	NMR spectroscopy	Cinzia AnnaVentura 2005
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[celecoxib]	2.04		7.0	45.0	NMR spectroscopy	Cinzia AnnaVentura 2005
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[celecoxib]	3.95		7.0	25.0	HPLC, NMR spectroscopy	Cinzia AnnaVentura 2006
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](2).[celecoxib]	2.15		7.0	25.0	NMR spectroscopy	Cinzia AnnaVentura 2005
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](2).[celecoxib]	2.56		7.0	37.0	NMR spectroscopy	Cinzia AnnaVentura 2005
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](2).[celecoxib]	2.84		7.0	45.0	NMR spectroscopy	Cinzia AnnaVentura 2005
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](2).[celecoxib]	2.15		7.0	25.0	HPLC, NMR spectroscopy	Cinzia AnnaVentura 2006
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[Disoxaril]	4.50		7.0	5.0	NMR spectroscopy, circular dichroism	Cinzia AnnaVentura 2006
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[Disoxaril]	4.46		7.0	15.0	NMR spectroscopy, circular dichroism	Cinzia AnnaVentura 2006
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[Disoxaril]	4.43		7.0	25.0	NMR spectroscopy, circular dichroism	Cinzia AnnaVentura 2006
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](2).[Disoxaril]	1.85		7.0	5.0	NMR spectroscopy, circular dichroism	Cinzia AnnaVentura 2006
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](2).[Disoxaril]	1.74		7.0	15.0	NMR spectroscopy, circular dichroism	Cinzia AnnaVentura 2006
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](2).[Disoxaril]	1.61		7.0	25.0	NMR spectroscopy, circular dichroism	Cinzia AnnaVentura 2006
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[2-(2’-hydroxyphenyl)benzimidazole]	2.41		7.0	25.0	fluorescence spectroscopy	Isiah M.Warner 1996
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[2-(2’-hydroxyphenyl)benzimidazole]	2.32		7.0	25.0	induced circular dichroism	Isiah M.Warner 1996
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[2-(2¢-hydroxyphenyl)benzoxazole]	2.66		7.0	25.0	fluorescence spectroscopy	Isiah M.Warner 1996
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[2-(2¢-hydroxyphenyl)benzoxazole]	2.44		7.0	25.0	induced circular dichroism	Isiah M.Warner 1996
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[2-(2’-hydroxyphenyl)benzothiazole]	2.40		7.0	25.0	fluorescence spectroscopy	Isiah M.Warner 1996
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[2-(2’-hydroxyphenyl)benzothiazole]	2.09		7.0	25.0	induced circular dichroism	Isiah M.Warner 1996
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[2-(2’-methoxyphenyl)benzothiazole]	2.72		7.0	25.0	fluorescence spectroscopy	Isiah M.Warner 1996
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[2-(2’-methoxyphenyl)benzothiazole]	2.72		7.0	25.0	induced circular dichroism	Isiah M.Warner 1996
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[bupivacaine]	2.39	0.94		25.0	HPLC	Gilles Dollo 1996
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[bupivacaine]	2.42	0.93		37.0	HPLC	Gilles Dollo 1996
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[etidocaine]	1.87	0.18		25.0	HPLC	Gilles Dollo 1996
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[etidocaine]	1.79	0.20		37.0	HPLC	Gilles Dollo 1996
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[lidocaine]	1.55	0.18		25.0	HPLC	Gilles Dollo 1996
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[lidocaine]	1.64	-0.15		37.0	HPLC	Gilles Dollo 1996
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[mepivacaine]	1.70	-0.52		25.0	HPLC	Gilles Dollo 1996
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[mepivacaine]	1.76	0.28		37.0	HPLC	Gilles Dollo 1996
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[prilocaine]	1.69	0.04		25.0	HPLC	Gilles Dollo 1996
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[prilocaine]	1.72	0.38		37.0	HPLC	Gilles Dollo 1996
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[arachidonylethanolamide]	5.87		7.4	25.0	HPLC	Pekka Jarho 1996
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[clofibrate]	3.32			25.0	NMR spectroscopy	S. Anguiano-Igea 1997
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[warfarin]	2.45		9.5	25.0	fluorescence spectroscopy	Mamoru Kamiya 1997
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[o-hydroxybenzoic acid]	3.33	2.32		15.0	pH Potentiometry	Emilio Aicart 1999
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[o-hydroxybenzoic acid]	3.26	2.30		20.0	pH Potentiometry	Emilio Aicart 1999
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[o-hydroxybenzoic acid]	3.20	2.18		25.0	pH Potentiometry	Emilio Aicart 1999
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[o-hydroxybenzoic acid]	3.14	2.15		30.0	pH Potentiometry	Emilio Aicart 1999
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[o-hydroxybenzoic acid]	3.03	2.00		40.0	pH Potentiometry	Emilio Aicart 1999
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[o-hydroxybenzoate]	2.23	1.48		15.0	pH Potentiometry	Emilio Aicart 1999
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[o-hydroxybenzoate]	2.11	1.30		20.0	pH Potentiometry	Emilio Aicart 1999
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[o-hydroxybenzoate]	2.02	1.30		25.0	pH Potentiometry	Emilio Aicart 1999
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[o-hydroxybenzoate]	1.98	1.30		30.0	pH Potentiometry	Emilio Aicart 1999
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[o-hydroxybenzoate]	1.85	1.18		40.0	pH Potentiometry	Emilio Aicart 1999
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[o-hydroxybenzoate]	2.15			25.0	speed of sound and conductivity experiments	Emilio Aicart 1999
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[m-hydroxybenzoic acid]	3.26	2.26		15.0	pH Potentiometry	Emilio Aicart 1999
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[m-hydroxybenzoic acid]	3.15	2.15		20.0	pH Potentiometry	Emilio Aicart 1999
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[m-hydroxybenzoic acid]	3.08	2.08		25.0	pH Potentiometry	Emilio Aicart 1999
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[m-hydroxybenzoic acid]	3.00	2.00		30.0	pH Potentiometry	Emilio Aicart 1999
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[m-hydroxybenzoic acid]	2.84	1.85		40.0	pH Potentiometry	Emilio Aicart 1999
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[m-hydroxybenzoate]	1.43	0.78		15.0	pH Potentiometry	Emilio Aicart 1999
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[m-hydroxybenzoate]	0.95	0.48		20.0	pH Potentiometry	Emilio Aicart 1999
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[m-hydroxybenzoate]	0.90	0.48		25.0	pH Potentiometry	Emilio Aicart 1999
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[m-hydroxybenzoate]	0.70	0.48		30.0	pH Potentiometry	Emilio Aicart 1999
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[m-hydroxybenzoate]	0.70			40.0	pH Potentiometry	Emilio Aicart 1999
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[p-hydroxybenzoic acid]	3.40	2.40		15.0	pH Potentiometry	Emilio Aicart 1999
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[p-hydroxybenzoic acid]	3.33	2.32		20.0	pH Potentiometry	Emilio Aicart 1999
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[p-hydroxybenzoic acid]	3.26	2.26		25.0	pH Potentiometry	Emilio Aicart 1999
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[p-hydroxybenzoic acid]	3.21	2.20		30.0	pH Potentiometry	Emilio Aicart 1999
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[p-hydroxybenzoic acid]	3.06	2.08		40.0	pH Potentiometry	Emilio Aicart 1999
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[p-hydroxybenzoate]	1.62	0.90		15.0	pH Potentiometry	Emilio Aicart 1999
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[p-hydroxybenzoate]	1.46	0.78		20.0	pH Potentiometry	Emilio Aicart 1999
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[p-hydroxybenzoate]	1.38	0.78		25.0	pH Potentiometry	Emilio Aicart 1999
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[p-hydroxybenzoate]	1.26	0.60		30.0	pH Potentiometry	Emilio Aicart 1999
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[p-hydroxybenzoate]	0.95	0.48		40.0	pH Potentiometry	Emilio Aicart 1999
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[palmoic acid]	2.53	1.00	10.8	25.0	fluorescence spectroscopy, circular dichroism	Koji Kano 1991
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[2,2'-dihydroxy-1,1'-dinaphthylmethane]	1.95		5.5	25.0	fluorescence spectroscopy, circular dichroism	Koji Kano 1991
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[3-hydroxy-2-naphthoic acid]	3.65	2.48	5.5	25.0	fluorescence spectroscopy, circular dichroism	Koji Kano 1991
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[2-naphthalenesulfonate]	2.94	0.03	7.2	25.0	calorimetric titration	Yoshihisa Inoue 1993

Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin isomeric purity >80 %

MW	HBA	HBD	LogP	CAS	Suppliers	Supplier IDs	Storage ID	Quantity	Class	PAINS
	None	None					CY-2004.2	None

SMILES:

Supramolecules

Name	log K	SD	pH	T(°C)	Method	Ref
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin isomeric purity >80 %](1).[diphenhydramine]	3.70			23.0	phase solubility	Pascal Le Corre 1998
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin isomeric purity >80 %](1).[diphenhydramine]	2.95			37.0	phase solubility	Pascal Le Corre 1998
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin isomeric purity >80 %](1).[Ebselen]	3.00		7.0	25.0	phase solubility	Kaneto Uekama 2002
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin isomeric purity >80 %](1).[N-(1-adamantylmethyl)-]	4.04	3.00	7.0	25.0	surface plasmon resonance (SPR)	Susan E. Brown 2003
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin isomeric purity >80 %](1).[N-octyl-]	2.81	1.70	7.0	25.0	surface plasmon resonance (SPR)	Susan E. Brown 2003
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin isomeric purity >80 %](1).[N-(4-tert-butyl benzyl)-]	3.72	2.48	7.0	25.0	surface plasmon resonance (SPR)	Susan E. Brown 2003
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin isomeric purity >80 %](1).[[1-(3,4-dimethoxy-benzyl)-6,7-dimethoxy-isoquinoline]]	1.99	0.05	7.0	25.0	Potentiometry	Lajos Barcza 2006
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin isomeric purity >80 %](1).[{(+)-(3S,4R)-3-ethyl-4-[(1-methyl.5-imidazolyl)-metyl]-tetrahydrofuran-2-on}]	2.02	0.03	7.0	25.0	Potentiometry	Lajos Barcza 2006
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin isomeric purity >80 %](1).[[(−)-(8S,9R)-6'-methoxy-cinchonanol]]	3.10	0.05	7.0	25.0	Potentiometry	Lajos Barcza 2006
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin isomeric purity >80 %](1).[ursodeoxycholic acid]	3.63		7.4	24.0	HPLC-method	G. Puglisi 1997
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin isomeric purity >80 %](1).[ursodeoxycholic acid]	3.28		7.4	37.0	HPLC-method	G. Puglisi 1997
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin isomeric purity >80 %](1).[ursodeoxycholic acid]	2.80		7.4	45.0	HPLC-method	G. Puglisi 1997
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin isomeric purity >80 %](1).[chenodeoxycholic acid]	2.75		7.4	25.0	HPLC-method	G. Puglisi 1997
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin isomeric purity >80 %](1).[sodium a,w-octyl dicarboxylate]	1.94	1.59	10.5	25.0	Apparent molar volume measurements	Ronald E. Verrall 2000
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin isomeric purity >80 %](1).[sodium a,w-decanyl dicarboxylate]	2.99	2.34	10.5	25.0	Apparent molar volume measurements	Ronald E. Verrall 2000
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin isomeric purity >80 %](1).[sodium a,w-dodecyl dicarboxylate]	3.34	2.91	10.5	25.0	Apparent molar volume measurements	Ronald E. Verrall 2000
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin isomeric purity >80 %](1).[harmane]	2.06	1.62	7.8	22.0	Fluorescence spectroscopy	B. del Castillo 2003
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin isomeric purity >80 %](1).[harmine]	2.05	1.34	7.8	22.0	Fluorescence spectroscopy	B. del Castillo 2003
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin isomeric purity >80 %](1).[Aflatoxin B1]	2.95	1.96	7.0		Fluorescence spectroscopy	Rosangela Marchelli 2003
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin isomeric purity >80 %](1).[Aflatoxin G1]	2.89	1.94	7.0		Fluorescence spectroscopy	Rosangela Marchelli 2003
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin isomeric purity >80 %](1).[Aflatoxin M3]	2.74	1.79	7.0		Fluorescence spectroscopy	Rosangela Marchelli 2003
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin isomeric purity >80 %](1).[Aflatoxin B2]	2.56	1.82	7.0		Fluorescence spectroscopy	Rosangela Marchelli 2003
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin isomeric purity >80 %](1).[Aflatoxin G2]	2.76	1.75	7.0		Fluorescence spectroscopy	Rosangela Marchelli 2003
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin isomeric purity >80 %](1).[5,10,15-tris(3,5-dicarboxylatophenyl)-20-phenylporphyrin]	4.08	3.00	7.0	25.0	Isothermal titration calorimetry	Koji Kano 2005
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin isomeric purity >80 %](1).[[(−)-(5R,6S)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-morphinan-6-ol]]	2.44	0.05	7.0	25.0	Potentiometry	Lajos Barcza 2006
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin isomeric purity >80 %](1).[{DL-endo-(-hydroxybenzeneacetic acid 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester}]	3.30	0.10	7.0	25.0	Potentiometry	Lajos Barcza 2006